Inmed Pharmaceuticals Inc (INM) Annual Balance Sheets

Annual · GAAP · USD millions
Access INM quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Inmed Pharmaceuticals Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Jun 30 2025) (Mar 31 2024) (Jun 30 2023) (Jun 30 2022)
Assets
Cash & cash equivalent2.20
Short-term Investments, Total0.04
Cash & Short-term Investments2.00
Accounts receivable0.00
Inventories0.00
Discontinued Operations0.18
Other Current Assets0.01
Prepaid Expense And Other Assets Current0.24
Total Current Assets2.68
Equipment/Property/Plant Net0.81
Intangible Assets0.00
Deferred Tax Assets, in Process Research and Development30.15
Other Assets, Noncurrent0.00
Total Assets3.03
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.84
Accrued Liabilities, Current0.28
Other Liabilities, Current0.00
Deferred Rent Credit, Current DE0.00
Discontinued Operation, Liabilities0.11
Total Current Liabilities1.96
Capital Lease and Other0.04
Total Long-term Debt0.04
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.35
Operating Lease Liability Noncurrent0.73
Total Liabilities1.96
Stockholders' Equity
Common Stock Value94.28
Additional Paid In Capital Common Stock36.89
Retained Earnings / Accumulated Deficit-130.23
Accumulated Other Comprehensive Income0.13
Other Equity0.13
Common Stockholder's Equity1.08
Total Stockholder's Equity1.08
Liabilities & Stockholder's Equity3.03
4 historic quarters locked

Sign in to unlock the full Inmed Pharmaceuticals Inc balance sheet history.

About Inmed Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-098419

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License